Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-10-26
1997-10-07
Allen, Marianne P.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, A61K 3817, C07K 14435
Patent
active
056748426
ABSTRACT:
The subject invention provides non-naturally occurring peptides capable of inhibiting growth factor-stimulated growth of cells. The peptide can be utilized to inhibit growth factor-stimulated growth, such growth factors including, for example, gonadotropins, peptide hormones, synthetic growth factors, and ligands, the ligand having a receptor that is a member of the steroid/thyroid hormone/vitamin receptor superfamily. Also provided are DNA sequences encoding the peptides and methods of producing and using the peptides.
REFERENCES:
patent: 4740461 (1988-04-01), Kaufman
patent: 4753879 (1988-06-01), Rosa et al.
patent: 4766075 (1988-08-01), Goeddel et al.
patent: 4853330 (1989-08-01), Goeddel et al.
patent: 4914027 (1990-04-01), Knapp et al.
patent: 5096696 (1992-03-01), Galanakis
patent: 5160483 (1992-11-01), Postlethwaite
patent: 5206164 (1993-04-01), Tecce et al.
patent: 5380712 (1995-01-01), Ballance et al.
patent: 5384250 (1995-01-01), Murgita
Allen et al., "Purification of alpha-fetoprotein from human cord serum with demonstration of its antiestrogenic activity," Biochimica et Biophysica Acts, 1202:135-142 (1993).
Bedo, et al., "Retinoic acid regulates growth hormone gene expression," Nature, 339:231-234 (May 18, 1989).
Bennett, et al., "Transformation of alpha-fetoprotein (AFP) to a negative regulator of estrogen-dependent growth by ligands of the steroid/thyroid hormone receptor superfamily," Abstract #1452, Proceedings of the American Association for Cancer Research, 34:224 (Mar. 1993).
Conti, et al., "Thyroid hormone effect on .alpha.-fetoprotein and albumin coordinate expression by a human hepatoma cell line," Biochimica et Biophysica Acta, 1008:315-321 (1989).
Dietrich, "New aspects of steroid homone dependent tumor growth," Arch. Geschwulstforsch 60(2):149-160 (1990).
Evans, "The Steroid and Thyroid Hormone Receptor Superfamily," Science, 240:889-895 (May 13, 1988).
Garreau, et al., "Phytoestrogrens: new ligands for rat and human .alpha.-fetoprotein," Biochimica et Biophysica Acta, 1094:339-345 (1991).
Gierthy, et al., "Correlation of in Vitro and in Vivo Growth Suppression of MCF-7 Human Breast Cancer by 2,3,7,8-Tetrachlorodibenzo-p-dioxin," Cancer Research, 53:3149-3153 (Jul. 1, 1993).
Gorin, et al., "The Evolution of .alpha.-Fetoprotein and Albumin," The Journal of Biological Chemistry, 256(4):1954-1059 (Feb. 25, 1981).
Jacobson, et al., "Inhibition of Estrogen-dependent Breast Cancer Growth by a Reaction Product of .alpha.-Fetoprotein and Estradiol," Cancer Research, 50:415-420, (Jan. 15, 1990).
Jacobson et al., "Estradiol-Induced Changes in Spectral and Biological Properties of Alpha-Fetoprotein," Tumor Biology, 11:104 (1990).
Keel, et al., "Purified Human Alpha Fetoprotein Inhibits Growth Factor-Stimulated Estradiol Production by Porcine Granulosa Cells in Monolayer Culture," Endocrinology, 130(6):3715-3717 (1992).
Keel, et al., "Purified human .alpha.-fetoprotein inhibits follicle-stimulating hormone-stimulated estradiol production by porcine granulosa cells in culture," Molecular and Cellular Endocrinology, 94:21-25 (1993).
Mizejewski, et al., "Stability of Complex Formation Between Estradiol and Murine Alpha-Fetoprotein," Abstract #7150, Clinical Research, (Spring 1977).
Mizejewski, et al., "Estradiol-activated .alpha.-fetoprotein suppresses the uterotropic response to estrogens," Proc. Natl. Acad. Sci. USA, 80:2733-2737 (May 1983).
Mizejewski, et al., "New Insights into AFP Structure and Function: Potential Biomedical Applications," in Alha-Fetoprotein and Congenital Disorders, Mizejewski, et al., Eds. Academic ress, Inc. New York, N.Y. p. 5-34 (1985).
Mizejewski, et al., "Studies of the Intrinsic Antiuterotropic Activity of Murine Alpha-Fetoprotein," Tumour Biology, 7:19-36 (1986).
Mizejewski, et al., "Alpha-Fetoprotein is a Dual Regulator of Growth in Estrogen-Responsive Tissues," in Biological Activities of Alpha.sub.1 -Fetoprotein, vol. I, Mizejewski, et al., Eds., CRC Press, Inc., Boca Raton, FL, pp. 71-82 (1987).
Mizejewski, et al., "AFP Modification of Biologic Response in Estrogen-Sensitive Tissues: Use of In Vivo and In Vitro Models," in Biological Activities of Alpha.sub.1 -Fetoprotein, vol. II, Mizejewski, et al., Eds., CRC Press, Inc., Boca Raton, FL, pp. 59-74 (1989).
Mizejewski, et al., "Alpha-fetoprotein can regulate growth in the uterus of the immature and adult ovariectomized mouse," J. Reprod. Fert, 85:177-185 (1989).
Mizejewski, et al., "Separation of the Estrogen-Activated Growth-Regulatory Forms of Alpha-Fetoprotein in Mouse Amniotic Fluid," Biology of Reproduction, 42:887-898 (1990).
Mizejewski, "An Apparent Dimerization Motif in the Third Domain of Alpha-fetoprotein: Molecular Mimicry of the Steroid/Thyroid Nuclear Receptor Superfamily,".
Morinaga, et al., "Primary structures of human .alpha.-fetoprotein and its mRNA," Proc. Natl. Acad. Sci. USA, 80:4604-4608 (Aug. 1983).
Nishi, et al., "Estrogen-Binding Site of Rat Alpha-Fetoprotein," Tumor Biology, 14:234 (1993).
Nishi, et al., "Localization of the estrogen-binding site of .alpha.-fetoprotein in the chimeric human-rat proteins," Proc. Natl. Acad. Sci. USA, 88:3102-3105 (Apr. 1991).
Numez, et al., "The Physicochemical and Biological Properties of Alpha-Fetoprotein Depend of its Ligand Environment," J. Nucl. Med. Allied Sci., 33 (Suppl. to No. 3):18-26 (1989).
Rosebrock, et al., "Immunoprecipitation Assay of Alpha-fetoprotein Synthesis by Cultured Mouse Hepatoma Cells Treated with Estrogens and Glucocorticords," Differentiation, 19:168-178 (1981).
Savu, et al., "Mouse .alpha..sub.1 -Fetoprotein and Albumin," The Journal of Biological Chemistry, 256(18):9414-9418 (Sep. 25, 1981).
Sonnenschein, et al., "Growth Inhibition of Estrogen-Sensitive tumor Cells in Newborn Rats. Probable Role of Alpha-Fetoprotein," J. Natl. Can. Inst., 63(3):835-841 (Sep. 1979).
Sonnenschein, et al., "Age-Dependent Growth Inhibition of Estrogen-Sensitive Rat Mammary Tumors. Probable Role of Alpha-Fetoprotein," J. Natl. Can. Inst., 64(5):1141-1146 (May 1980).
Sonnenschein, et al., "Growth Inhibition of Estrogen-Sensitive Rat Mammary Tumors. Effect of an Alpha-Fetoprotein-Secreting Hepatoma" J. Natl. Can. Inst., 64(5):1147-1152 (May 1980).
Soto, et al., "Control of growth of estrogen-sensitive cells: Role for .alpha.-fetoprotein," Proc. Natl. Acad. Sci. USA, 77(4):2084-2087 (Apr. 1980).
Wahli, et al., "Superfamily of seroid nuclear receptors: positive and negative regulators of gene expression," The FASEB Journal, 5:2243-2249 (Jun. 1991).
Wan, et al., "The effects of retinoic acid on the expression of .alpha.-fetoprotein and albumin genes in rat hepatoma cell lines," Differentiation, 50:107-111 (1992).
Allen Marianne P.
Health Research Incorporated
LandOfFree
Growth inhibitory peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth inhibitory peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth inhibitory peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357360